We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
-9.55%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$6.91B
AUM Growth
-$872M
Cap. Flow
-$3.53M
Cap. Flow %
-0.05%
Top 10 Hldgs %
70.94%
Holding
141
New
10
Increased
20
Reduced
67
Closed
19

Sector Composition

Rank Sector Weight
1 Financials 22.69%
2 Consumer Discretionary 16.64%
3 Healthcare 14.3%
4 Communication Services 12.68%
5 Consumer Staples 11.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RARE icon
101
Ultragenyx Pharmaceutical
RARE
$2.49B
$946K 0.01%
21,765
-22,585
-51% -$1.23M
KHC icon
102
Kraft Heinz
KHC
$33.2B
$929K 0.01%
21,583
GOOGL icon
103
Alphabet (Google) Class A
GOOGL
$4.11T
$908K 0.01%
17,380
LKQ icon
104
LKQ Corp
LKQ
$6.75B
$900K 0.01%
+37,951
New +$1.03M
WP
105
DELISTED
Worldpay, Inc.
WP
$831K 0.01%
+10,869
New +$945K
PBYI icon
106
Puma Biotechnology
PBYI
$397M
$797K 0.01%
39,179
-15,869
-29% -$476K
SNA icon
107
Snap-on
SNA
$21.4B
$731K 0.01%
5,030
MCD icon
108
McDonald's
MCD
$193B
$705K 0.01%
3,972
-3,523
-47% -$625K
FIS icon
109
Fidelity National Information Services
FIS
$23.9B
$647K 0.01%
6,311
AVY icon
110
Avery Dennison
AVY
$12.8B
$584K 0.01%
6,500
SUPN icon
111
Supernus Pharmaceuticals
SUPN
$2.72B
$576K 0.01%
17,325
-6,148
-26% -$264K
HIND
112
Vyome Holdings
HIND
$14.4M
0
FSTX
113
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$541K 0.01%
13,025
-6,966
-35% -$313K
GPRK icon
114
GeoPark
GPRK
$607M
$345K 0.01%
25,113
-5,973
-19% -$95.6K
EXEL icon
115
Exelixis
EXEL
$14B
$264K ﹤0.01%
13,446
-345
-3% -$6.15K
BLUE
116
DELISTED
bluebird bio
BLUE
$236K ﹤0.01%
184
-5
-3% -$7.67K
ESPR
117
DELISTED
Esperion Therapeutics
ESPR
$224K ﹤0.01%
4,874
-125
-3% -$6.02K
XLRN
118
DELISTED
Acceleron Pharma
XLRN
$224K ﹤0.01%
5,146
-132
-3% -$6.59K
AGIO icon
119
Agios Pharmaceuticals
AGIO
$2.08B
$163K ﹤0.01%
3,531
-91
-3% -$5.62K
ACAD icon
120
Acadia Pharmaceuticals
ACAD
$4.45B
$128K ﹤0.01%
7,943
-204
-3% -$3.96K
RDUS
121
DELISTED
Radius Health, Inc.
RDUS
$118K ﹤0.01%
7,153
-183
-2% -$3.08K
SNDX icon
122
Syndax Pharmaceuticals
SNDX
$1.68B
$57K ﹤0.01%
12,896
-331
-3% -$1.81K
ALKS icon
123
Alkermes
ALKS
$8.08B
-161,466
Closed -$6.85M
BMY icon
124
Bristol-Myers Squibb
BMY
$130B
-120,199
Closed -$7.46M
C icon
125
Citigroup
C
$215B
-4,949,524
Closed -$355M

Similar funds

C WorldWide Group's Q4 2018 Portfolio in Review

As of Q4 2018, C WorldWide Group held 141 positions worth $6.91B, down 11% from $7.79B the previous quarter. Its ten largest holdings account for 71% of the portfolio.

C WorldWide Group's Q4 2018 filing shows 10 new, 20 increased, 67 reduced and 19 closed positions. Its largest new stake was American Tower: 2,128,357 shares worth $337M. The largest sale was Citigroup, an estimated $355M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • C WorldWide Group's largest Q4 2018 buy was American Tower: 2,128,357 shares worth $337M.
  • C WorldWide Group added most to Procter & Gamble in Q4 2018, an estimated $47.1M increase.
  • C WorldWide Group's biggest Q4 2018 reduction was Visa, cutting an estimated $19.2M.
  • C WorldWide Group fully exited Citigroup in Q4 2018, selling an estimated $355M.
  • C WorldWide Group's ten largest holdings make up 71% of its $6.91B portfolio in Q4 2018.
  • C WorldWide Group opened 10 new positions and closed 19 in Q4 2018.
  • C WorldWide Group's portfolio value fell 11% quarter-over-quarter to $6.91B.

Based on C WorldWide Group's 13F filing for Q4 2018, filed 12 Feb 2019.